Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Brighton Jones LLC

Brighton Jones LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 9,158 shares of the medical equipment provider’s stock after selling 156 shares during the period. Brighton Jones LLC’s holdings in Intuitive Surgical were worth $4,074,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Creekmur Asset Management LLC increased its position in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at about $26,000. Able Wealth Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Delos Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares in the last quarter. Finally, LRI Investments LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.6 %

ISRG stock opened at $490.01 on Friday. The company has a market cap of $173.81 billion, a price-to-earnings ratio of 88.45, a PEG ratio of 5.41 and a beta of 1.39. The business has a fifty day simple moving average of $467.17 and a 200-day simple moving average of $424.26. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $496.18.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the prior year, the firm earned $1.18 EPS. The firm’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 2,818 shares of the stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $1,291,010.34. Following the transaction, the executive vice president now directly owns 298 shares in the company, valued at approximately $136,522.74. The disclosure for this sale can be found here. In the last three months, insiders sold 53,120 shares of company stock worth $25,528,753. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ISRG shares. Evercore ISI lowered their price objective on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a report on Friday, July 19th. Morgan Stanley boosted their price target on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Truist Financial boosted their price target on Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research note on Tuesday, July 16th. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Finally, Barclays upped their target price on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $446.45.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.